Please assess the completion status of the following clinical trial:

Trial Title: Effect of Muscle Relaxation Reversal on the Success Rate of Motor Evoked Potential Recording

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age range from 18 to 65 years old~* American Society of Anesthesiologists (ASA) physical status I to II~Exclusion Criteria:~* BMI ≥35 kg/m-2~* History of epilepsy or use of antiepileptic drugs~* Personal history or family history of malignant hyperthermia~* Allergies to sugammadex; NMBs or other medication(s) used during general anesthesia~* Hemoglobin \<110 g/L~* TceMEP stimulation or recorded site infection~* Preoperative neurological dysfunction in both upper extremities~* Cardiac pacemaker~* Pregnancy and lactation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Sugammadex group (Type: EXPERIMENTAL): None
- control group (Type: SHAM_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).